Page 16 - 《中国药房》2025年4期

（1）：81-85. steroidal anti-inflammatory drug （NSAID） therapy in
[25] HUNT R，LAZEBNIK L B，MARAKHOUSKI Y C，et al. patients with hypertension，cardiovascular，renal or gastro‐
International consensus on guiding recommendations for intestinal comorbidities：joint APAGE/APLAR/APSDE/
management of patients with nonsteroidal antiinflamma‐ APSH/APSN/PoA recommendations[J]. Gut，2020，69（4）：
tory drugs induced gastropathy-ICON-G[J]. Euroasian J 617-629.
Hepatogastroenterol，2018，8（2）：148-160. [37] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于规
[26] AUBRUN F，NOUETTE-GAULAIN K，FLETCHER D， 范开展药品临床综合评价工作的通知[EB/OL].（2021-
et al. Revision of expert panel’s guidelines on postopera‐ 07-21）[2024-08-26]. http：//www.nhc.gov.cn/yaozs/s2908/
tive pain management[J]. Anaesth Crit Care Pain Med， 202107/532e20800a47415d84adf3797b0f4869. shtml?
2019，38（4）：405-411. R0NMKk6uoz.
[27] SCHMIDT M，LAMBERTS M，OLSEN A S，et al. Cardio‐ Office of the National Health Commission. Notice from
vascular safety of non-aspirin non-steroidal anti-inflammatory the Office of the National Health Commission on stan‐
drugs：review and position paper by the Working Group dardizing the clinical comprehensive evaluation of drugs
for Cardiovascular Pharmacotherapy of the European [EB/OL].（2021-07-21）[2024-08-26]. http：//www.nhc.gov.
Society of Cardiology[J]. Eur Heart J Cardiovasc Pharma‐ cn/yaozs/s2908/202107/532e20800a47415d84adf3797b0f-
cother，2016，2（2）：108-118. 4869.shtml?R0NMKk6uoz.
[28] SOLOMON D H，ELAINE HUSNI M，LIBBY P A，et al. [38] 赵志刚，董占军，刘建平. 中国医疗机构药品评价与遴选
The risk of major NSAID toxicity with celecoxib，ibupro‐ 快速指南：第二版[J].医药导报，2023，42（4）：447-456.
fen，or naproxen：a secondary analysis of the PRECISION ZHAO Z G，DONG Z J，LIU J P. A quick guideline for
trial[J]. Am J Med，2017，130（12）：1415-1422.e4. drug evaluation and selection in Chinese medical institu‐
[29] RUSCHITZKA F，BORER J S，KRUM H，et al. Differen‐ tions：the second edition[J]. Her Med，2023，42（4）：
tial blood pressure effects of ibuprofen，naproxen，and 447-456.
celecoxib in patients with arthritis：the PRECISION-ABPM [39] VAN DURME C M，WECHALEKAR M D，LANDEWÉ
（prospective randomized evaluation of celecoxib inte‐ R B，et al. Non-steroidal anti-inflammatory drugs for
grated safety versus ibuprofen or naproxen ambulatory acute gout[J]. Cochrane Database Syst Rev，2021，12
blood pressure measurement） trial[J]. Eur Heart J，2017， （12）：CD010120.
38（44）：3282-3292. [40] VAN DER GAAG W H，ROELOFS P D，ENTHOVEN W
[30] OBEID S，LIBBY P，HUSNI E，et al. Cardiorenal risk of T，et al. Non-steroidal anti-inflammatory drugs for acute
celecoxib compared with naproxen or ibuprofen in arthri‐ low back pain[J]. Cochrane Database Syst Rev，2020，4
tis patients：insights from the PRECISION trial[J]. Eur （4）：CD013581.
Heart J Cardiovasc Pharmacother，2022，8（6）：611-621. [41] ENTHOVEN W T M，ROELOFS P D D M，DEYO R A，
[31] TEERAWATTANANON C， TANTAYAKOM P， et al. Non-steroidal anti-inflammatory drugs for chronic
SUWANAWIBOON B，et al. Risk of perioperative bleeding low back pain[J]. Cochrane Database Syst Rev，2016，2
related to highly selective cyclooxygenase-2 inhibitors：a （2）：CD012087.
systematic review and meta-analysis[J]. Semin Arthritis [42] KROON F P B，VAN DER BURG L R A，RAMIRO S，et
Rheum，2017，46（4）：520-528. al. Non-steroidal anti-inflammatory drugs（NSAIDs）for
[32] DAVIDSON B L，VERHEIJEN S，LENSING A W A，et axial spondyloarthritis（ankylosing spondylitis and non-
al. Bleeding risk of patients with acute venous thromboem‐ radiographic axial spondyloarthritis）[J]. Cochrane Data‐
bolism taking nonsteroidal anti-inflammatory drugs or base Syst Rev，2015，2015（7）：CD010952.
aspirin[J]. JAMA Intern Med，2014，174（6）：947-953. [43] 谢菡，陈思煌，陈大宇，等. 不同厂家氟比洛芬酯注射液
[33] VILLA ZAPATA L，HANSTEN P D，PANIC J，et al. Risk 有效性和安全性的真实世界研究[J]. 医药导报，2023，42
of bleeding with exposure to warfarin and nonsteroidal （2）：193-197.
anti-inflammatory drugs：a systematic review and meta- XIE H，CHEN S H，CHEN D Y，et al. Comparison of
analysis[J]. Thromb Haemost，2020，120（7）：1066-1074. efficacy and safety between flurbiprofen axetil injections
[34] CABASSI A，TEDESCHI S，PERLINI S，et al. Non- from two manufacturers：a real-world study[J]. Her Med，
steroidal anti-inflammatory drug effects on renal and car‐ 2023，42（2）：193-197.
diovascular function：from physiology to clinical practice [44] Norwegian Institute of Public Health. ATC/DDD index
[J]. Eur J Prev Cardiol，2020，27（8）：850-867. 2024[EB/OL].[2024-05-01]. https：//atcddd.fhi.no/atc_ddd_
[35] HÖRL W H. Nonsteroidal anti-inflammatory drugs and index.
the kidney[J]. Pharmaceuticals（Basel），2010，3（7）：2291- （收稿日期：2024-08-26 修回日期：2025-01-02）
2321. （编辑：林 静）
[36] SZETO C C，SUGANO K，WANG J G，et al. Non-

· 394 · China Pharmacy 2025 Vol. 36 No. 4 中国药房 2025年第36卷第4期